文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

作者信息

Planchard D, Popat S, Kerr K, Novello S, Smit E F, Faivre-Finn C, Mok T S, Reck M, Van Schil P E, Hellmann M D, Peters S

出版信息

Ann Oncol. 2019 May;30(5):863-870. doi: 10.1093/annonc/mdy474. Epub 2019 Dec 4.

DOI:10.1093/annonc/mdy474
PMID:31987360
Abstract
摘要

相似文献

[1]
Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

Ann Oncol. 2019-5

[2]
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.

Ann Oncol. 2020-2

[3]
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2016-9

[4]
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014-9

[5]
Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1.

Acta Oncol. 2021-9

[6]
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2012-10

[7]
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2010-5

[8]
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.

Lung Cancer. 2014-3-16

[9]
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2010-5

[10]
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

Ann Oncol. 2014-2-20

引用本文的文献

[1]
Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study.

EClinicalMedicine. 2025-8-21

[2]
Noninvasive Prediction of Programmed Cell Death Protein-Ligand 1 Expression in Locally Advanced Non-small Cell Lung Cancer by F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Metabolic Habitats: A Multicenter Radiomic and Biological Study.

Ann Surg Oncol. 2025-8-29

[3]
A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC.

Cancers (Basel). 2025-5-30

[4]
Exploring cellular plasticity and resistance mechanisms in lung cancer: Innovations and emerging therapies.

J Pharm Anal. 2025-5

[5]
Single-cell multimodal analysis reveals tumor microenvironment predictive of treatment response in non-small cell lung cancer.

Sci Adv. 2025-5-23

[6]
A prognostic signature of Glutathione metabolism-associated long non-coding RNAs for lung adenocarcinoma with immune microenvironment insights.

Front Immunol. 2025-2-10

[7]
Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.

Pharmacoecon Open. 2025-5

[8]
Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer.

J Inflamm Res. 2024-9-11

[9]
Radiomics nomogram for predicting chemo-immunotherapy efficiency in advanced non-small cell lung cancer.

Sci Rep. 2024-9-6

[10]
Plasma lipidomics profiling in predicting the chemo-immunotherapy response in advanced non-small cell lung cancer.

Front Oncol. 2024-7-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索